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Using interdialytic ambulatory blood pressure (BP) recordings
as the reference standard, we compared the performance of
routine, standardized and home BP monitoring in 104
predominantly black patients on chronic hemodialysis for at
least 3 months. Dialysis unit BP recordings were averaged
over 2 weeks and home BP over 1 week. Awake ambulatory
BP ofX135 mmHg systolic orX85 mmHg diastolic was taken
as evidence of hypertension. Average awake ambulatory BP
was 128.1721.6/73.5713.5 mmHg, home BP 141.3721.9/
78.7711.9 mmHg, standardized pre-dialysis BP 141.7722.6/
74.2713.5 mmHg and post-dialysis 119.9720.5/
69.1713.1 mmHg, routine pre-dialysis 145.4721.8/
79.0713.1 mmHg and post-dialysis 131.5719.2/
72.5711.4 mmHg. Sixty-three percent of the patients had
well-controlled BP by ambulatory BP monitoring and isolated
diastolic hypertension was rare (3%). The standard deviation
of the differences between ambulatory and routine
pre-dialysis BP was 17.6 mmHg, routine post-dialysis was
16.1 mmHg, standardized pre-dialysis was 16.4 mmHg,
standardized post-dialysis was 14.1 mmHg, and home BP was
14.2 mmHg. The area under receiver operating characteristic
curves was similar for home and standardized BP but lower
for routine BP. Home systolic BP of X150 mmHg averaged
over 1 week had the best combination of sensitivity (80%)
and specificity (84.1%) in diagnosing systolic hypertension –
present in 94% of the hypertensive dialysis patients. Home
BP monitoring is similar to standardized recording of BP in
hemodialysis patients. A systolic BP threshold of 150 mmHg
at home averaged over 1 week serves as a useful predictor of
hypertension diagnosed by ambulatory BP monitoring.
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Identification and treatment of hypertension is an ongoing
challenge that nephrologists face when managing patients on
hemodialysis. Blood pressure (BP) control is believed to be
important in reducing morbidity and mortality in this high-
risk population,1 although there is no consensus on target
BP.2 Difficulties in making an accurate diagnosis of
hypertension in hemodialysis patient arise in part due to
large swings in BP with the hemodialysis procedure. We have
previously shown that 2-week routine BP recordings in the
dialysis unit when averaged can give a qualitative estimate of
presence or absence of hypertension.3 However, thresholds
for these qualitative estimates were such that high sensitivity
and specificity were not shared by any individual BP
recording. Thus, substantial uncertainty exists on making
an accurate diagnosis of hypertension in hemodialysis
patients.4
Subsequent investigations have shown that routine
assessment of BP measurement does not agree well with
readings obtained by standardized methods.5 Pilot data also
demonstrated that home BP recordings may be promising in
making a more accurate diagnosis of hypertension in
hemodialysis patients.6 These studies did not explore whether
standardized or home BP recordings can improve the
prediction of hypertension as assessed by ambulatory BP
monitoring. However, it became clear that the accuracy of
recordings of standardized BP as well as home BP needed
further evaluation in making a diagnosis of hypertension in
hemodialysis patients. Accordingly, we designed this pro-
spective cross-sectional study to assess the relationship
between BP recordings obtained in the dialysis unit by
routine and standardized methods; home BP recordings
obtained by the patients; and the reference standard of 44-h
interdialytic ambulatory BP recordings.
RESULTS
Between September 2003 and February 2005, we recruited
150 patients from four dialysis units staffed by the
nephrology faculty of Indiana University, Indianapolis. The
sample was drawn from 355 patients of which 48% were
women, 36% were diabetic, and 72% were black patients.
Twenty-five patients had inadequate or refused ambula-
tory BP recordings. In five patients, the cuff-size used for
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home BP recordings was inappropriately small for the arm
circumference; these patients were excluded from the
analysis. Six patients had no monitor-recorded BP readings
and 10 recorded o6 readings. After excluding these patients,
104 patients were available for overall BP analysis.
The clinical characteristics of the remaining 104 patients
are shown in Table 1. The population was predominantly
black with limited education and low income. Average Kt/V,
serum albumin and hemoglobin reflect a generally healthy
population. Interdialytic weight gain was 2.771.5 kg. All
patients were on three times weekly dialysis and were
prescribed a dialysis time of 238725 min, blood flow rate
of 405732 ml/min and dialysate flow rate of 754788 ml/min.
The characteristics of the sample, except ethnicity, were
similar to the population from which it was drawn. We
further analyzed, why fewer white patients were recruited.
Ethnicity of 126 patients who were screened but who did not
participate were analyzed. Forty-one black (76%), 12 (22%)
white patients, and one (2%) Asian met the recruitment
criteria but refused participation. Fifty-five (76%) black, 15
white patients (21%), and two (3%) Asians did not meet one
of the inclusion or exclusion criteria. Because 27/126 (21%)
white patients did not meet eligibility or refused participa-
tion, our sample comprised of more black participants
than the overall composition from which the sample was
derived from.
Majority of the patients received antihypertensive drugs,
with an average of 2.2 drugs in those who took antihyper-
tensives (Table 2). Beta blockers were the most commonly
utilized antihypertensive agent. Average time that ambulatory
BP recorder was worn was 4577.5 h, whereas the successful
recordings were made over 36.379 h. An average of 97719
recordings per patient were obtained, of which 36710 were
recordings on day 1 during the awake state and 30710 were
awake recordings on day 2. The average number of home BP
recordings was 1674. Awake ambulatory BPs were similar to
44-h interdialytic ambulatory BPs reflecting the absence of
nocturnal decline in most patients. As expected, pre-dialysis
BPs were higher than post-dialysis BPs.
Figure 1 shows that 66/104 patients (63%) had well-
controlled BP by awake ambulatory BP recordings. Fifty of
these 66 patients were on antihypertensive drugs (treated,
controlled hypertension) and 16/66 (24%) were not on any
medications (normotensive). Of 48/104 (37%) who were
hypertensive, only three patients (3%) had isolated diastolic
hypertension, whereas 35 (34%) had systolic hypertension.
Of those with systolic hypertension 17 (16%) had isolated
systolic hypertension, and 18 (17%) had combined systolic
and diastolic hypertension. As diastolic hypertension is
nearly always accompanied by systolic hypertension in
hemodialysis patients, only systolic BP recordings were
analyzed further.
Table 1 | Clinical characteristics of the study population
Clinical characteristic n=104
Age (years) 55.9712.6
Men 73 (70%)
Race
White 7 (7%)
Black 95 (91%)
Other 2 (2%)
Years of education 11.972.1
12 year education or more 87 (84%)
Income o$25 000 per year 93 (89%)
Pre-dialysis weight (kg) 81.3718.1
Post-dialysis weight (kg) 78.6717.6
BMI (kg/m2) 26.875.9
Years of end-stage renal disease 575.2
Current alcohol use 25 (24%)
Smoking
Current 42 (40%)
Former 30 (29%)
Never 32 (31%)
Diabetes mellitus 46 (44.2%)
Etiology of end-stage renal disease
Diabetes mellitus 33 (32%)
Hypertension 58 (56%)
Glomerulonephritis 6 (6%)
Obstruction 1 (1%)
Other 6 (6%)
Kt/V 1.670.44
Albumin (g/dl) 3.870.4
Hemoglobin (g/dl) 12.571.5
7Indicates standard deviation. Values in parentheses represent percent of patients.
Table 2 | Antihypertensive drug use and BP measurements
Number receiving antihypertensive drugs 86 (83%)
Number of antihypertensives in users 2.271.0
Nature of antihypertensive agent
Dihydropyridine calcium channel blockers 38 (37%)
Non-dihydropyridine calcium-channel blockers 4 (4%)
Beta-blockers 66 (63%)
Alpha-blockers 6 (6%)
Centrally acting agents 57 (55%)
Vasodilators 17(16%)
ACE Inhibitors 44 (42%)
Angiotension receptor blockers 15 (14%)
44-hour ambulatory BP (mmHg) 127.9721.5/72.7713.0
Awake ambulatory BP (mmHg) 128.1721.6/73.5713.5
Home BP (mmHg) 141.3721.9/78.7711.9
Standardized BP (mmHg)
Pre-dialysis 141.7722.6/74.2713.5
Post-dialysis 119.9720.5/69.1713.1
Routine BP (mmHg)
Pre-dialysis 145.4721.8/79.0713.1
Post-dialysis 131.5719.2/72.5711.4
BP, blood pressure.
7Indicates standard deviation. Values in parentheses represent percent of patients.
Standardized and routine BP are average of 2-week recordings, whereas home BP
are average of 1-week recording. Medications reported are those actually taken by
the patients.
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The receiver operating characteristic (ROC) curves for
various systolic BPs are shown in Figure 2. The area under
the curve (AUC) for 2-week averaged dialysis unit BP was
higher for post-dialysis standardized measurement compared
to post-dialysis routine BP. Standardized post-dialysis BP had
a higher AUC compared to routine post-dialysis BP
(P¼ 0.045). Routine pre-dialysis and post-dialysis AUCs
were similar (P¼ 0.395). Also, standardized pre-dialysis and
post-dialysis AUCs were similar (P¼ 0.162). AUC for home
BP recordings was as good as 2-week averaged standardized
BP measurements (P¼ 0.241 for comparison with pre-stand-
ardized and P¼ 0.729 for comparison with post-standardized)
and superior to pre-dialysis routine BP (P¼ 0.029 for
comparison). The optimal cutoff thresholds for home BP were
148.9 mmHg that gave 82.9% sensitivity and 84.1% specificity
with the highest Youden index of 0.669 (Table 3).
Clinically relevant sensitivities and specificities that assist
in making a diagnosis of hemodialysis hypertension are
shown in Table 4. Routine pre-dialysis systolic BP of
X146 mmHg has a sensitivity of 82.9% but a specificity
of only 65.2%. By contrast, post-dialysis systolic BP of
X130.8 mmHg had a sensitivity of 80.4% and specificity of
72.5%. Standardized pre-dialysis BP of X147.1 mmHg had a
sensitivity of 80.0% and specificity of 78.3%. Standardized
post-dialysis systolic BP ofX121.9 mmHg had a sensitivity of
80.0% and specificity of 79.7%. The best combination
of sensitivity and specificity was seen with systolic home
Table 4 | BP thresholds for diagnosing hemodialysis hypertension
Two-week averaged routine BP Two-week averaged standardized BP
Pre-HD Post-HD Pre-HD Post-HD One-week averaged home BP
Sensitivity
=95% 136.8 (95.7, 49.3) 123.6 (97.1, 53.6) 135.6 (94.3, 58.0) 114.9 (97.1, 69.6) 134.7 (97.1, 62.3)
=90% 140.6 (91.4, 56.5) 125.4 (91.4, 62.3) 143.3 (91.4, 69.6) 116.4 (91.4, 71.0) 140.7 (91.4, 69.6)
=80% 146 (82.9, 65.2) 130.8 (80.4, 72.5) 147.1 (80.0, 78.3) 121.9 (80.0, 79.7) 150 (80.0, 84.1)
Specificity
=95% 165.8 (40.0, 95.7) 151.5 (42.9, 95.7) 164.4 (42.9, 95.7) 139.8 (51.4, 95.7) 161.6 (37.1, 95.7)
=90% 162.4 (45.7, 91.3) 145.5 (60.0, 91.3) 162.8 (42.9, 91.3) 130.7 (68.6, 91.3) 156.3 (57.1, 91.3)
=80% 154.4 (60.0, 81.2) 138.3 (65.7, 81.2) 151.9 (60.0, 81.2) 123.9 (74.3, 81.2) 147.4 (82.9, 81.2)
Sensitivity and specificity associated with the systolic BP are shown in parentheses. The sensitivity and specificities selected are those that may be clinically relevant.
BP, blood pressure; HD, hemodialysis.
Table 3 | BP thresholds for diagnosing hemodialysis hypertension
Two-week averaged routine BP Two-week averaged standardized BP
Pre-HD Post-HD Pre-HD Post-HD One-week averaged home BP
Area under ROC curve (95% CI) 0.823 (0.744–0.902) 0.859 (0.789–0.929) 0.854 (0.783–0.924) 0.904 (0.849–0.960) 0.890 (0.829–0.950)
Youden index (diagnostic efficiency) 0.509 0.553 0.610 0.667 0.669
BP threshold 145.3 130.0 143.3 114.9 148.9
Sensitivity 86.7 82.8 91.4 97.1 82.9
Specificity 65.2 72.5 69.6 69.6 84.1
BP, blood pressure; CI, confidence interval; HD, hemodialysis.
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Figure 1 | Distribution of systolic and diastolic BPs shows that
IDH is uncommon. Sixty-three percent of the population had
well-controlled awake ambulatory BPs (NT), 17% had systolic and
diastolic hypertension (SDH) and 16% isolated systolic hypertension
(ISH). The cloud is jittered 5% for clarity of presentation.
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Figure 2 | ROC curves of routine and standardized hemodialysis
unit BP obtained before and after dialysis and home BPs. The
dotted curve represents the pre-dialysis BPs. The diagonal dotted line
indicates a hypothetical test with no predictive value. The AUC for
home BP was as good as standardized measurement of BPs.
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BP of X150 mmHg (rounded off to nearest 10) that was
associated with a sensitivity of 80% and specificity of 84.1%.
AUC of the ROC curves analyzed for 125 patients who had
adequate ambulatory recordings and dialysis unit BP
recordings and 114 patients who had at least one home BP
recorded confirmed the above results (data not shown).
These additional analyses showed that routine BP recordings
had the lowest AUC. Post-dialysis recordings had a better
AUC compared to pre-dialysis recordings. Home BP record-
ings averaged over 1 week had a performance that was similar
to standardized BP measurements.
Table 5 shows the average difference and the standard
deviation of the difference between BP measurements. Pre-
dialysis routine systolic BP has the greatest overestimation,
16.2 mmHg, of awake ambulatory systolic BP. By contrast,
post-dialysis routine systolic BP overestimated ambulatory
BP by only 2.4 mmHg. The standard deviation of the
difference was greatest for pre-dialysis routine BP and least
for home BP. The Bland–Altman plots illustrate these
relationships in Figure 3 for dialysis unit BPs and Figure 4
for home BP recordings.
Quantitative analyses of test performance using the
methods proposed by Minini et al.7 revealed differences
between methods of measurements. The homogeneity index
of corrected errors were in the following order: Routine pre-
HD (16.3 mmHg), standardized pre-HD (15.6 mmHg),
routine post-HD (13.9 mmHg), home BP (13.6 mmHg) and
standardized post-BP (13.0 mmHg). There was highly
significant differences between the methods of measurements
(Po0.0001). Comparisons between all possible pairs showed
statistical differences between standardized post-HD BP vs
routine pre-HD BP (P¼ 0.021), and marginal differences
between standardized pre-HD BP vs standardized post-HD
BP (P¼ 0.057) and home BP vs routine pre-HD BP
(P¼ 0.065).
DISCUSSION
The threshold BP for making a diagnosis of hypertension
should be both sensitive and specific. An ideal threshold
would be 100% sensitive and specific. This is rarely achieved.
Accordingly, a threshold that is both 80% sensitive and 80%
specific is considered acceptable since it has a high accuracy
in making a diagnosis of hypertension. Our study shows that
routine BP measurements, even when averaged over 2 weeks,
have marginal performance in the diagnosis of hemodialysis
hypertension. This combination of an acceptable sensitivity
and specificity was seen only for home BP recording or post-
dialysis standardized BP. One week averaged systolic home
BP of X150 mmHg or post-dialysis standardized BP of
X122 mmHg has both high sensitivity and specificity to
predict hypertension assessed by ambulatory BP monitoring.
While home BP monitoring may perform well in an educated
population should come as little surprise.8 That the
performance of home BP recordings was at least as good as
Table 5 | Agreement between routine, standardized and home systolic BP and awake ambulatory systolic BP
Two-week averaged routine BP (n=125) Two-week averaged standardized BP (n=125) One-week averaged
home BP (n=114)Pre-HD Post-HD Pre-HD Post-HD
Non-ambulatory BP minus
awake ambulatory BP (95% CI)
16.2 (13.2 to 19.2) 2.4 (0.4 to 5.2) 12.4 (9.7–15.2) 9.1 (11.6 to 6.6) 12.2 (9.6 to 14.8)
SDD between non-ambulatory
BP and awake ambulatory BP
16.9 16.1 15.6 14.4 14.2
BP=blood pressure, CI=confidence interval, HD=hemodialysis, SDD=standard deviation of the difference.
Average of routine systolic and awake ambulatory systolic BP
Average of standardized systolic and awake ambulatory systolic BP
R
ou
tin
e-
am
bu
la
to
ry
St
d-
am
bu
la
to
ry
100 120 140 160 180 200
Post-dialysis
100 120 140 160 180 200
100 120 140 160 180 200 100 120 140 160 180 200
−40
−20
0
20
40
60
−40
−20
0
20
40
60
−40
−20
0
20
40
60
−40
−20
0
20
40
60
Pre-dialysis
Post-dialysisPre-dialysis
Figure 3 | Bland–Altman plots for hemodialysis unit – routine and
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is jittered 5% for clarity of presentation.
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resource-intensive, nurse-recorded, standardized recordings
averaged over 2 weeks demonstrates that home BP measure-
ment technique is robust and can be readily taught and
utilized even by hemodialysis patients with less education.
Systolic hypertension either with or without diastolic
hypertension was more prevalent compared to isolated
diastolic hypertension confirms our earlier result.3 As isolated
diastolic hypertension is relatively uncommon, the focus of
treatment should be on systolic BP control.9 The prevalence
of well-controlled systolic BP or normotension of 63% was
much higher than 24% we reported earlier. In our previous
study, we selected those patients in whom we wanted to judge
the adequacy of BP control or to make a diagnosis of
hypertension. Whereas the better control rate of hypertension
may be due to greater recognition of this problem, it is more
likely that the results of the present study were due to lack of
selection bias that may have existed in our previous report.
Because adequate control in epidemiological surveys is
estimated at only 30%,10 it is possible that hemodialysis
patients, like those with chronic kidney disease not on
dialysis,11 may have a large white-coat effect. We speculate
that the lower prevalence of true hypertension found with
ambulatory BP measurements may contribute to the failure
of epidemiological studies using routine BP monitoring
techniques to uncover hypertension as a risk factor for
cardiovascular disease.12,13 Post-dialysis BP recordings had
slightly better predictive performance based on AUC and
narrower limits of agreement on the Bland–Altman plot. In
cohort studies, high post-dialysis – not pre-dialysis – systolic
BP correlates with poor survival.12,13 For any given systolic
BP, post-dialysis hypertension is more specific in diagnosing
hypertension and therefore reflects a greater cardiovascular
BP load compared to pre-dialysis hypertension.
The average standardized systolic post-dialysis BP was
about 10 mmHg lower compared to routine post-dialysis BP.
We found that using routine post-dialysis systolic BP of
X130.8 mmHg or standardized post-dialysis systolic BP of
X121.9 mmHg at least 80% sensitivity can be achieved in
diagnosing hypertension in hemodialysis patients. The lower
threshold for standardized measurement may reflect the time
elapsed from the end of the dialysis session to the time of
measurements. Whereas the routine post-dialysis BP was
measured in the dialysis chair, those obtained via the
standard method required walking away from the dialysis
chair, seated rest for at least 5 min and measurement of BP.
BP is known to fall post-dialysis and this may simply reflect
the time-dependent fall in systolic BP.6,14 Rahman et al.5 have
also reported that in 55% of the patients, the post-dialysis
systolic BP was at least 10 mmHg higher than the standard
reading. Routine systolic post-dialysis recordings overesti-
mated post-dialysis standardized recordings by 13.6 mmHg.
These results are also consistent with Mitra et al.15 who have
reported that 20 min post-dialysis BP may be the best
predictor of hypertension in hemodialysis patients.
Which technique of measurement of BP – home, dialysis
unit, or interdialytic ambulatory – is more reliable in
predicting target organ damage is currently unknown. An
ideal reference standard would be one where hard outcomes
such as cardiovascular deaths and events are related to a
certain level of the risk factor and modulation of the level of
risk-factor leads to differences in outcomes. Interdialytic
ambulatory systolic BP has been linked to cardiovascular
mortality in a sample size that was limited to 57 treated
hypertensive patients on hemodialysis.16 Averaged dialysis
unit BP measurements have failed to show such a relation-
ship.2 Furthermore, ambulatory BP monitoring is more
reproducible and accurate compared to dialysis unit BP
measurements.17 Thus, ambulatory BP monitoring is accu-
rate, reproducible and correlates with cardiovascular death.
Although no study has demonstrated that modulation of BP
in hemodialysis patients can influence outcomes, it appears
reasonable to use ambulatory BP as the ‘gold standard’.
Some limitations of our study must be addressed. The
majority of the patients in our study were black. Although
ethnicity should not influence the measurement of BP,
whether these data are applicable to non-black subjects is
uncertain. Standardized measurements of BP are resource-
intensive and may not be practical outside the research
setting. Although standardized measurement of BP had a
better performance than routine recordings, home BP
monitoring appears to be a better alternative than standar-
dized measurements in clinical practice. Whether at least
1-week average home BP monitoring is required for a firm
diagnosis is also unclear from the present analysis and will be
the subject of future analyses. It is possible that 1-week home
BP monitoring may be cumbersome for many patients,
reducing its feasibility in the clinical setting. Thus, shorter
periods of home BP monitoring may need to be tested for
adequacy in predicting ambulatory BP while retaining the
sensitivity and specificity seen in this study.
We conclude that 1 week averaged home systolic BP of
X150 mmHg has the best combination of sensitivity and
specificity to diagnose hypertension in hemodialysis patients.
Home BP monitoring is as good as standardized measure-
ments of BP taken before and after dialysis and outperforms
the routine measurements of BP as currently performed in
the dialysis units even when averaged over 2-weeks. By
reducing the magnitude of the white coat effect, home BP
monitoring may better clarify the relationship between
systolic hypertension and cardiovascular outcomes in hemo-
dialysis patients and improve the ability of clinicians in
making a more accurate diagnosis of hypertension. Standar-
dized recording of BP provides similar information as home
BP in predicting ambulatory BP.
MATERIALS AND METHODS
Subjects
Patients 18 years or older who had been on chronic hemodialysis for
more than 3 months, and were free of vascular, infectious or
bleeding complications within 1 month were enrolled in the study.
Those who missed two hemodialysis treatments or more over 1
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month, abused drugs, had chronic atrial fibrillation or body mass
index of 40 kg/m2 or more were excluded. Patients who had a change
in dry weight or antihypertensive drugs within 2 weeks were also
excluded. Presence or absence of hypertension was not a selection
criterion. All patients underwent a standard three times a week
dialysis at one of the four dialysis units in Indianapolis affiliated
with Indiana University.
Anthropometric and demographic characteristics and antihyper-
tensive medications actually taken by the patient were recorded. The
study was approved by the Institutional Review Board of Indiana
University and Research and Development Committee of the
Roudebush VA Medical Center, Indianapolis and all subjects gave
written informed consent.
Ambulatory BP monitoring
Ambulatory BP monitoring was performed after the mid-week
hemodialysis session for 44 h. Ambulatory BPs were recorded every
20 min during the day (0600–1100) and every 30 min during the
night (2200–0600) using a Spacelab 90207 ABP monitor (SpaceLabs
Medical Inc., Redmond, WA, USA) in the non-access arm, as
performed previously.18 Recordings began immediately after hemo-
dialysis and terminated immediately before the subsequent dialysis.
Accuracy of ambulatory BP recordings was confirmed against
auscultated BP at baseline. Data were analyzed using ABP Report
Management System software, version 1.03.05 (SpaceLabs Medical
Inc, Redmond, WA, USA). Ambulatory BP and heart rates were
averaged over the entire course of recording, as well as separately
during the day and during night.
Dialysis patients have abnormal sleep cycles and the division of
day and night by the clock is artificial. Therefore, awake and asleep
readings were calculated for each patient by self-reported sleep and
awake times by means of a diary. A weighted average of the awake
readings on each of the 2 days of ambulatory BP monitoring was
taken to represent average awake ambulatory BP. For the purposes of
this study, awake ambulatory BP of 135/85 mmHg or more was
considered hypertensive.19 Those patients who had o14 recordings
on awake ambulatory BP were excluded from analysis (n¼ 25).
Dialysis unit BPs
Dialysis unit BP recordings as measured by the dialysis unit staff
before and after dialysis were collected prospectively at the time of
the patient visit. These BP recordings were obtained using the
sphygmomanometer equipped with hemodialysis machines without
a specified technique and were averaged over 2 weeks. Thus, each
patient had six pre-dialysis and six post-dialysis BP recordings to
provide routine dialysis unit BP.
BP was also recorded using a standard technique following at
least a 5-min rest and using a validated oscillometric device (HEM
907, Omron Healthcare, Vernon Hills, IL, USA) by research nurses
trained in this technique. Three readings at each visit were averaged
to provide one recording. Pre-dialysis and post-dialysis recordings
were averaged separately over 2 weeks to provide a standardized
dialysis unit BP.
Home BP monitoring
Home BP monitoring was performed over 1 week using a validated
self-inflating automatic oscillometric device (HEM 705 CP, Omron
Healthcare). The protocol specified home BP monitoring in the first
week. Patients were instructed in the use of this monitor and asked
not to share this monitor with others. Patients were asked to record
their BP three times daily – on waking up, between noon and 1900
and at bedtime – and log this on a chart provided for this purpose.
As this monitor is equipped with a memory and printer, we only
used those recordings that were recorded in the memory of the
monitor. Those providing o6 recordings were excluded (see
Results).
Data analysis
To analyze the sensitivity and specificity of hemodialysis unit BPs,
we generated ROC curves, including AUC and their 95% confidence
intervals.20 The interdialytic BP load is most reproducibly estimated
using multiple measurements using the ambulatory BP monitor and
was taken as the reference standard.17 The ROC curve depicts the
relation between true-positive results (number with hypertension on
awake ambulatory BP) and false-positive results (number with well-
controlled BP on awake ambulatory BP) for each BP. The greater the
area under ROC curve, the better the diagnosis by the respective BP.
The best cutoff BP was calculated based on the Youden index.21 The
Youden index, a measure of overall diagnostic effectiveness, is the
maximum vertical distance or difference between the ROC curve
and the diagonal or chance line; it occurs at the cut-point that
optimizes the BP’s differentiating ability when equal weight is given
to sensitivity and specificity. Youden index was calculated as
sensitivityþ specificity1. The higher the index, the better the
prediction at the cutoff point. Bland–Altman plots were created for
the analysis of agreement.22 In this analysis, average difference
between awake ambulatory BP and dialysis unit BP or awake
ambulatory BP and home BP was calculated along with the 95%
confidence interval and the standard deviation of the difference.
Accuracy of various techniques to measure BP was analyzed
quantitatively using the methods proposed by Minini et al.7 The
homogeneity index of corrected errors for systolic BP served as the
classification index of accuracy of the measurement techniques
compared to the gold standard to awake ambulatory BP. The
homogeneity index is the standard deviation of the leverage
corrected raw residuals of the test BP regressed against the gold
standard (for details of the analysis see Minini et al.7). All analyses
were conducted using SPSS Software version 13.0 (SPSS Inc.,
Chicago, IL, USA). Area under the ROC curves was compared using
Stata 8.0 (Stata Corp, College Station, TX, USA). The P-values
reported are two-sided and taken to be significant at o0.05.
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